Dr. Andrews Hill’s Ivermectin meta-analysis, from University of Liverpool, England, supported by The Access to COVID-19 Tools (ACT) Accelerator. Presentation from MedinCell Workshop (16 December). “In conclusion, in this meta-analysis we are seeing using standard WHO grade criteria a faster time to viral clearance, a shorter duration of hospitalisation, 43% higher rates of clinical recovery…
Category: Resources
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
In March 2020, an expert panel called the Front Line COVID-19 Critical Care Alliance (FLCCC) was created and led by Professor Paul E. Marik, with the goal of continuously reviewing the rapidly emerging basic science, translational, and clinical data in order to gain insight into and to develop a treatment protocol for COVID-19. At the…
Dr John Campbell: Ivermectin and COVID 19
A summary of current findings from Dr John Campbell.
Video: Dr Pierre Kory testifies to senate committee about I-MASK+ protocol on 8 December 2020
Appearing as a witness Tuesday morning before the Senate Committee on Homeland Security and Governmental Affairs—which held a hearing on “Early Outpatient Treatment: An Essential Part of a COVID-19 Solution”— Dr. Pierre Kory, President of the Frontline COVID-19 Critical Care Alliance (FLCCC), called for the government to swiftly review the already expansive and still rapidly…